Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$498M |
| 2 |
Micron Technology
MU
|
+$374M |
| 3 |
Amazon
AMZN
|
+$356M |
| 4 |
Accenture
ACN
|
+$318M |
| 5 |
Advanced Micro Devices
AMD
|
+$301M |
Top Sells
| 1 |
Apple
AAPL
|
+$684M |
| 2 |
Meta Platforms (Facebook)
META
|
+$630M |
| 3 |
Tesla
TSLA
|
+$595M |
| 4 |
Chevron
CVX
|
+$497M |
| 5 |
Shopify
SHOP
|
+$439M |
Sector Composition
| 1 | Healthcare | 19.38% |
| 2 | Technology | 18.55% |
| 3 | Consumer Staples | 10.17% |
| 4 | Consumer Discretionary | 9.68% |
| 5 | Financials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2951
Forte Biosciences
FBRX
$131M
| $475K | ﹤0.01% |
17,765
+9,097
| +105% | +$243K |
|
2952
GoDaddy
GDDY
$20.1B
| $475K | ﹤0.01% |
+6,700
| New | +$475K |
|
2953
Lesaka Technologies
LSAK
$362M
| $475K | ﹤0.01% |
135,000
-8,700
| -6% | -$30.6K |
|
2954
Citius Pharmaceuticals
CTXR
$20.6M
| $473K | ﹤0.01% |
15,631
+412
| +3% | +$12.5K |
|
2955
Alset
AEI
$103M
| $472K | ﹤0.01% |
92,151
-13,949
| -13% | -$71.4K |
|
2956
Solid Biosciences
SLDB
$420M
| $472K | ﹤0.01% |
67,485
-27,110
| -29% | -$190K |
|
|
SRCL
2957
DELISTED
Stericycle Inc
SRCL
| $472K | ﹤0.01% |
11,220
-34,200
| -75% | -$1.44M |
|
|
ORC
2958
Orchid Island Capital
ORC
$1.04B
| $470K | ﹤0.01% |
57,360
+54,440
| +1,864% | +$446K |
|
2959
Value Line
VALU
$357M
| $470K | ﹤0.01% |
10,700
| – | – |
|
2960
ACNB Corp
ACNB
$471M
| $467K | ﹤0.01% |
15,556
-15,100
| -49% | -$453K |
|
2961
Bright Horizons
BFAM
$6.45B
| $467K | ﹤0.01% |
+8,100
| New | +$467K |
|
2962
Cocrystal Pharma
COCP
$16.2M
| $467K | ﹤0.01% |
133,702
-8,151
| -6% | -$28.5K |
|
2963
Lisata Therapeutics
LSTA
$19.2M
| $467K | ﹤0.01% |
100,922
-7,317
| -7% | -$33.9K |
|
2964
Scully Royalty
SRL
$76.2M
| $467K | ﹤0.01% |
63,114
-9,600
| -13% | -$71K |
|
|
HARP
2965
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $467K | ﹤0.01% |
48,104
+16,368
| +52% | +$159K |
|
2966
FVCBankcorp
FVCB
$240M
| $466K | ﹤0.01% |
30,375
-16,875
| -36% | -$259K |
|
2967
Tiptree Inc
TIPT
$956M
| $466K | ﹤0.01% |
43,300
-11,700
| -21% | -$126K |
|
|
BBU
2968
Brookfield Business Partners
BBU
$2.4B
| $465K | ﹤0.01% |
23,900
-14,800
| -38% | -$288K |
|
2969
Emerson Radio
MSN
$8.89M
| $465K | ﹤0.01% |
808,188
-78,600
| -9% | -$45.2K |
|
2970
Ameris Bancorp
ABCB
$5.1B
| $464K | ﹤0.01% |
10,369
-22,300
| -68% | -$998K |
|
2971
Bank of Montreal
BMO
$90.5B
| $464K | ﹤0.01% |
5,300
-173,800
| -97% | -$15.2M |
|
2972
Lifetime Brands
LCUT
$88.4M
| $464K | ﹤0.01% |
68,500
-19,906
| -23% | -$135K |
|
2973
Assembly Biosciences
ASMB
$168M
| $463K | ﹤0.01% |
23,517
+4,575
| +24% | +$90.1K |
|
2974
Backblaze
BLZE
$534M
| $463K | ﹤0.01% |
93,200
+49,900
| +115% | +$248K |
|
|
AEVA
2975
Aeva Technologies
AEVA
$903M
| $460K | ﹤0.01% |
49,209
+22,389
| +83% | +$209K |
|